M&A Update – December 22

– KRTX to be acquired by BMY for $330 cash per share, 53.4% premium, $12.7 billion
– DSKE to be acquired by TFII for $8.30 cash per share, 69.0% premium, $1.1 billion
– THRX to be acquired by Concentra Biosciences for $3.90 to $4.05 cash per share + CVR, 9.5% premium, -$22.3 enterprise value
– OLK / TMO pulled and refiled German regulatory approval, UK CMA to open Phase 1 investigation, closing mid 2024
– CWBC / CVCY filed S-4/a, votes Feb 8, closing Q2 2024
– PATI / United Petroleum Transports deal closed
– LVOX / NICE delisting notice, closing Dec 22
– IMGN / ABBV filed PREM14a, closing mid 2024
– PNT tender expires